ERBB2 and breast carcinoma: Inhibition of G6PD has been proven to trigger the upregulation of autophagy in lapatinib-resistant cancer cells.24 Consistent with this finding, our study also demonstrated that the combined treatment of pyrotinib and chrysin induced an apparently lower level of autophagy within HER2-positive breast cancer cells in the presence of G6PD overexpression.